Figure:
coronavirus, COVID-19
Emergency physicians have all encountered that situation wherein just minutesa patient will likely die if you don't do something. Even so, we do not shock patients in asystole, give thrombolytics in codes, or stab ballpoint pens into tracheas. We are not even doing blind pericardial sticks or giving high-dose epi or IV calcium. Heck, we don't even do precordial thumps anymore.
There is also a suggestion that the standard epinephrine we give could be causing higher mortality. (J Am Coll Cardiol. 2014;64[22]:2360.) Why in these most dire and immediately critical circumstances aren't we willing to try something? The answer is because we have data, some clinical and some historical, that these things on the whole don't work. Or, as in the case of epinephrine, they may cause more harm.
If we are capable of being mostly rational in MacGyver emergency situations, shouldn't it be easier for less critical patients and for sure with outpatients? The harms that result from the need to do something outweigh any potential benefit (e.g., antibiotics for the probable viral illness causing Clostridium difficile, anaphylaxis, diarrhea, vaginal yeast infections, etc.). Regardless of illness severity, it appears that we struggle to maintain scientific reason. Why?
Because we are treating fear. This is no crime. Fear is real. Fear is common among us and our patients, families, friends, and staff. Fear is powerful, and it is fueled by many sources. I am not against admitting and addressing those fears. But if we treat them with unproven therapies, the harm and cost can be catastrophic. What if we treated this fear like we treat our codes, with information, with data, with data from history?
Look at COVID-19 and the history of infectious disease, including our very recent history of virology. The epidemics and pandemics of the world (with some exceptions like Yersinia, cholera, typhus, and tuberculosis) have largely been viral (smallpox, polio, influenza, yellow fever, dengue, chickenpox, measles, mumps, rubella, hepatitis, rabies, HIV, Ebola, and Zika). With the exception of HIV and hepatitis C, the solution in essentially every one of those viral epidemics and pandemics was not a medication.
The medications for HIV and hepatitis C took 10 to 25 years from the time the virus was identified until we had a curative treatment. The solution in every one of these illnesses was a combination of public health measures, behavior change, and an effective vaccine. That is not my opinion; it is the data that history, even very recent history, gives us.
It is not reasonable to think that we are going to invent an antiviral medication six months after we discover a novel coronavirus, and it is magical thinking to hope and believe that a medication already out there for some other disease just might work. Even if we find there is some statistical significance in a relatively small controlled trial; it will take time to validate the findings, and they will likely be marginal at best (like Tamiflu).
Some people say that we have experimental reasons or even animal data that show it could help. You could fill pharmaceutical graveyards with the drugs that met that standard and never made it to market. We have heard about the immunomodulatory effects of azithromycin for 35 years with no proven clinical outcome data to support it. There was a five- to 10-year span where people wanted to use it for coronary artery disease and acute myocardial infarction because of its anti-inflammatory properties. This idea was appropriately killed in the WIZARD study. (JAMA. 2003;290[11]:1459; https://bit.ly/3ddzwVD.)
Now, here we are again with a drug so overused it barely treats anything effectively anymore, and we are throwing it at COVID-19 for its mystical anti-inflammatory properties. (Let's toss in a statin while we are at it.)
Some people say, What can it hurt? You don't want these people to die! The answer is, despite good intentions, drugs like chloroquine have a very narrow margin of therapeutic safety, and drugs like hydroxychloroquine and azithromycin can prolong the QT and cause life-threatening rhythms, especially in conjunction with ondansetron and whatever else the patient is on (antipsychotics) that may prolong the QT. I don't want them to die. That is why I would not use an unproven drug that could kill them. And I would include antiviral medications, anti-cytokines, protease-inhibitors, convalescent plasma, eye of newt, and whatever else is added to the line-up if we keep falling behind. The history of medicine is filled with harmful therapies employed because trying something somehow felt better than doing no harm.
The Infectious Diseases Society of America released guidelines on treating and managing patients with COVID-19. (Clin Infect Dis. 2020 Apr 27; https://bit.ly/3dfTHlS.) Infectious disease experts, who are just as prone to want to do something as you and I (maybe more because it is their specialty), have said not to empirically throw unproven medications like hydroxychloroquine, azithromycin, remdesivir, or anything else at COVID-19 unless the patient is enrolled in a randomized controlled trial or part of a local or collaborative registry. This is completely consistent with what Anthony Fauci, MD, the director of the National Institute of Allergy and Infectious Diseases, and all the other public health and infectious disease specialists have been saying from day one.
Maybe history's data will be wrong this time. I hope so. But we are not doing nothing by withholding unproven therapies. We medically support the patient without good medications like we do for a lot of diseases. We advocate for public health measures of physical distancing, masks, and handwashing for 20 seconds while we wait for a vaccine. This has been our history of what works.
The first patient of 45 healthy volunteers was given a COVID-19 vaccine in April. Maybe next summer, we will find out it works. While we are waiting, we will educate Americans better than we have with the influenza vaccine, that if a vaccine has only 50 percent efficacy, its effectiveness could be 90 percent or more if everyone takes it. The information of medical history and our expertise in science and statistical reasoning must be kept in our white coat pocket. We must run this code of COVID-19 with our heads and not let our fear harm the patient
Dr. Mosleyis an emergency physician in Wichita, KS.
The rest is here:
Breaking News: The Harm of Treating Fear in COVID-19 : Emergency Medicine News - LWW Journals
- ST-Segment Elevation Myocardial Infarction - verywell.com [Last Updated On: May 12th, 2018] [Originally Added On: May 12th, 2018]
- Myocardial infarction (Heart Attack) - Health Facts [Last Updated On: June 21st, 2018] [Originally Added On: June 21st, 2018]
- Heart Attack and Acute Coronary Syndrome - Lab Tests Online [Last Updated On: June 21st, 2018] [Originally Added On: June 21st, 2018]
- Myocardial Infarction - ECGpedia [Last Updated On: September 21st, 2018] [Originally Added On: September 21st, 2018]
- Myocardial Infarction Clinical Presentation: History ... [Last Updated On: September 25th, 2018] [Originally Added On: September 25th, 2018]
- Myocardial infarction diagnosis - Wikipedia [Last Updated On: September 25th, 2018] [Originally Added On: September 25th, 2018]
- Myocardial Infarction Treatment & Management: Approach ... [Last Updated On: October 9th, 2018] [Originally Added On: October 9th, 2018]
- Myocardial infarction - Simple English Wikipedia, the free ... [Last Updated On: October 18th, 2018] [Originally Added On: October 18th, 2018]
- ST-Segment Elevation Myocardial Infarction [Last Updated On: October 18th, 2018] [Originally Added On: October 18th, 2018]
- ECG localization of myocardial infarction / ischemia and ... [Last Updated On: October 18th, 2018] [Originally Added On: October 18th, 2018]
- Heart Attack (Myocardial Infarction) Symptoms | Cleveland Clinic [Last Updated On: November 15th, 2018] [Originally Added On: November 15th, 2018]
- Myocardial Infarction (Heart Attack) Ischemia Pathophysiology, ECG, Nursing, Signs, Symptoms Part 1 [Last Updated On: November 15th, 2018] [Originally Added On: November 15th, 2018]
- Myocardial Infarction (MI) NCLEX Questions [Last Updated On: November 30th, 2018] [Originally Added On: November 30th, 2018]
- Myocardial Infarction NCLEX Review (Part 1) [Last Updated On: December 3rd, 2018] [Originally Added On: December 3rd, 2018]
- Acute Myocardial Infarction, Myocardial infection. Patient [Last Updated On: December 4th, 2018] [Originally Added On: December 4th, 2018]
- Heart Attack | Myocardial Infarction | MedlinePlus [Last Updated On: December 16th, 2018] [Originally Added On: December 16th, 2018]
- Heart Attack (Myocardial Infarction) - medicinenet.com [Last Updated On: December 17th, 2018] [Originally Added On: December 17th, 2018]
- Myocardial infarction (acute): Early rule out using high ... [Last Updated On: December 20th, 2018] [Originally Added On: December 20th, 2018]
- Conditions We Treat: Myocardial Infarction | Johns Hopkins ... [Last Updated On: December 23rd, 2018] [Originally Added On: December 23rd, 2018]
- Myocardial Infarction - Heart Home Page [Last Updated On: December 25th, 2018] [Originally Added On: December 25th, 2018]
- Myocardial infarction: signs symptoms and treatment ... [Last Updated On: December 25th, 2018] [Originally Added On: December 25th, 2018]
- ECGs in Acute Myocardial Infarction - ACLS Medical Training [Last Updated On: December 25th, 2018] [Originally Added On: December 25th, 2018]
- Myocardial Infarction - Eccles Health Sciences Library [Last Updated On: December 27th, 2018] [Originally Added On: December 27th, 2018]
- Myocardial Infarction: Practice Essentials, Background ... [Last Updated On: December 27th, 2018] [Originally Added On: December 27th, 2018]
- Myocardial infarction - Wikipedia [Last Updated On: December 27th, 2018] [Originally Added On: December 27th, 2018]
- Nursing Care Plan for Myocardial Infarction | NRSNG [Last Updated On: December 29th, 2018] [Originally Added On: December 29th, 2018]
- Cardiovascular disease - Myocardial infarction | Britannica.com [Last Updated On: January 11th, 2019] [Originally Added On: January 11th, 2019]
- Heart Attack (Myocardial Infarction) - Cedars-Sinai [Last Updated On: January 11th, 2019] [Originally Added On: January 11th, 2019]
- Top 5 MI ECG Patterns You Must Know | LearntheHeart.com [Last Updated On: January 11th, 2019] [Originally Added On: January 11th, 2019]
- Anterior Myocardial Infarction LITFL ECG Library Diagnosis [Last Updated On: January 11th, 2019] [Originally Added On: January 11th, 2019]
- Electrocardiography in myocardial infarction - Wikipedia [Last Updated On: January 11th, 2019] [Originally Added On: January 11th, 2019]
- Myocardial Infarction Therapeutics Market, Share, Growth ... [Last Updated On: March 13th, 2019] [Originally Added On: March 13th, 2019]
- Heart Attack (Myocardial Infarction) - Drugs.com [Last Updated On: April 20th, 2019] [Originally Added On: April 20th, 2019]
- STEMI (ST Elevation Myocardial Infarction): diagnosis ... [Last Updated On: April 20th, 2019] [Originally Added On: April 20th, 2019]
- Heart attack - Symptoms and causes - Mayo Clinic [Last Updated On: April 20th, 2019] [Originally Added On: April 20th, 2019]
- Cardiovascular models including myocardial infarction ... [Last Updated On: April 27th, 2019] [Originally Added On: April 27th, 2019]
- Myocardial infarction - Osmosis Video Library [Last Updated On: May 1st, 2019] [Originally Added On: May 1st, 2019]
- Myocardial Infarction [Last Updated On: September 17th, 2019] [Originally Added On: September 17th, 2019]
- Creatinine Rises After RAS Inhibitor Initiation Tied to Worse Outcomes - Renal and Urology News [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Ventricular Tachycardia Treatment Market Growth in Technological Innovation, Competitive Landscape Mapping the Trends and Outlook - NewsVarsity [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- FDA Action Alert: Merck and Amarin - BioSpace [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Resverlogix Provides Update on BETonMACE Phase 3 Trial Toronto Stock Exchange:RVX - GlobeNewswire [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Marijuana Use Linked to Improved Acute-HF Hospital Survival - Medscape [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Population Health vs. Personalized Medicine: Lost in Translation? - American Council on Science and Health [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Bariatric Surgery Tied to Less MACE in Obesity, Diabetes - Medscape [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- A Novel Algorithm for Improving the Diagnostic Accuracy of Prehospital ST-Elevation Myocardial Infarction - DocWire News [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Shock and Awe: ARNI for Acute HF May Be Safely Started in ICU - Medscape [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Global Myocardial Infarction Treatment Market Will Reach USD 1726.3 million by end of 2022 - Market News Store [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Frequency and Factors Related to Not Receiving Acute Reperfusion Therapy in Patients with ST Elevation Myocardial Infarction; A Single Specialty... [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Research Offers 10-Year Forecast on Myocardial Infarction Treatment Market - Rapid News Network [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- University of Colorado study suggests Cannabis aids in surviving heart... - Communities Digital News [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- SRH part of regional system award recognizing care for heart attacks - Index-Journal [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- TherOx Announces Key SuperSaturated Oxygen Therapy Presentations at TCT 2019 - Yahoo Finance [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Incidence, Characteristics and Outcomes in Very Young Patients with ST Segment Elevation Myocardial Infarction - DocWire News [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Health Recovery After Acute MI Similar in Young Adults With and Without Diabetes - The Cardiology Advisor [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Rapid Diagnosis Protocol for Chest Pain Does Not Improve Outcomes - Diagnostic and Interventional Cardiology [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Diagnosis of Myocardial Infarction At Autopsy: AECVP Reappraisal in the Light of the Current Clinical Classification - DocWire News [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Global Myocardial Infarction Drug Market 2019 BioCardia, Inc., Biscayne Pharmaceuticals, Inc., Capricor Therapeutics, Inc., Cell - Market News Times [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Abiomed to Highlight Importance of Optimal PCI Treatment to Improve Outcomes for High-Risk Patients at TCT 2019 - Yahoo Finance [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- ENTRUST-AF PCI Supports Safety of Dual Therapy With Edoxaban - Medscape [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Preoperative opioid use leads to perioperative consequences in foot and ankle surgery - Healio [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- CV, General Safety of Long-Term PPI Use Examined - The Cardiology Advisor [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Effect of Delayed vs Immediate Interventions in Transient STEMI - The Cardiology Advisor [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Cardiorenal Disease Is the Most Common CVD Manifestation in Patients With T2D - Endocrinology Advisor [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- DAPA-HF Published: 'Stunning Consistent Benefit With Dapagliflozin' - Medscape [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Geomagnetic Disturbances and Cardiovascular Mortality Risk - On Health - BMC Blogs Network [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Reconsidering the Safety of Intravenous Thrombolysis for Ischemic Stroke After Recent Myocardial Infarction - Neurology Advisor [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- The Lowdown on Lipoprotein(a) - Medscape [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Protamine use found to significantly reduce reoperations for patients who undergo carotid endarterectomy - Vascular News [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Left Main Treated With PCI or CABG Have Similar Outcomes at Five Years - Diagnostic and Interventional Cardiology [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Sen. Sanders released from the hospital after heart attack - WXYZ [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- E-Selectin Gene Haplotypes are Associated with the Risk of Myocardial Infarction - DocWire News [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- BioVentrix Enrolls and Treats First Patient in REVIVE-HF European RCT for Ischemic Heart Failure Patients - P&T Community [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Quantitative Flow Ratio guided Residual Functional SYNTAX Score for Risk Assessment in Patients with ST-Segment Elevation Myocardial Infarction... [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Coronary Calcium Scan: The Role of Calcium Scoring in Preventing a First Myocardial Infarction - Consultant360 [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Sanders plans to 'change the nature' of campaign after heart attack - New York Post [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Early MI Linked to High Recurrent Events, Mortality - Medscape [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Sudden Cardiac Arrest and Ventricular Arrhythmias following first type I Myocardial Infarction in the Contemporary Era - DocWire News [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- E-Cigarette Use and Myocardial Infarction - Physician's Weekly [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Sen. Bernie Sanders had heart attack; chest pains diagnosed as myocardial infarction - KIRO Seattle [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]